|drug3057||Serial seroconversion measurements in hospital employees during the COVID-19 pandemic Wiki||1.00|
There is one clinical trial.
The novel coronavirus (COVID-19) is affecting the way many people live their lives, including seeking medical care and maintaining good self-care to keep healthy. Additionally, in the event many people become critically ill at once, COVID-19 has the possibility of overwhelming hospitals to the point where they have to make decisions about how to determine who receives intensive care and life-support measures. Many hospitals as well as local or state governments have been working on policies to determine how to make these decisions. This study seeks to learn about how COVID-19 has affected the way patients and healthcare providers care for themselves and about their thoughts and concerns about policies that may "ration" life-support resources.
Description: Improvement in knowledge item score of 2 points on follow up after intervention delivery and at final follow upMeasure: Improvement in knowledge surrounding SRA policy Time: 1 month, 6 months
Description: Improvement in anxiety scale of 2 points responses on follow up after intervention delivery and at final follow upMeasure: Improvement in anxiety surrounding SRA policy Time: 1 month, 6 months
Description: Improvement in trust scale of 2 points responses on follow up after intervention delivery and at final follow upMeasure: Improvement in trust surrounding SRA policy Time: 1 month, 6 months
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports